A look at IP litigation in 2019 and the year ahead, and some advice on how medical device companies can safeguard their intellectual property.
AdvaMed states that the huge tax increase will have a significant impact on employment and investment.
It’s good news for device companies, but industry associations and stakeholders are still seeking a permanent solution.
Will the return of the 2.3% excise tax change how medtech companies do business?
Tariffs on imports will hurt business expansion in Asia.
The candidates have said little about what they will do for the medical device industry.
The Senate vote is good news for industry, which has fought against the tax for years.
In order to keep innovation and manufacturing in the United States, device companies need federal and local support.
The medical device tax has a “profound negative effect” on the nation’s jobs and innovation, AdvaMed President and CEO Stephen Ubl and Medical Imaging & Technology Alliance Executive Director Gail Rodriguez explain in an editorial.
The U.S. Medical Device Excise Tax continues to draw scorn from industry advocates as a jobs killer. However, new data from a survey tells a different story about how executives are compensating for costs of the tax, and that story varies considerably by size of company.